McCart Reed AE, Kalinowski L, Simpson PT, Lakhani SR. Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast Cancer Res. 2021;23:6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JH, Park S, Park HS, Park BW. Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study. World J Surg Oncol. 2010;8:34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jung YS, Na KY, Kim KS, Ahn SH, Lee SJ, Park HK, et al. Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program. J Breast Cancer. 2011;14:229–36.

Article  PubMed  PubMed Central  Google Scholar 

Taha SR, Boulos F. E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes. Histopathology. 2024. https://doi.org/10.1111/his.15295.

Article  PubMed  Google Scholar 

Lobo J, Petronilho S, Newell AH, Coach J, Harlow G, Cruz A, et al. E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients. Mod Pathol. 2019;32:1574–86.

Article  CAS  PubMed  Google Scholar 

El Sharouni MA, Postma EL, van Diest PJ. Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findings. Virchows Arch. 2017;471:707–12.

Article  PubMed  PubMed Central  Google Scholar 

Canas-Marques R, Schnitt SJ. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls. Histopathology. 2016;68:57–69.

Article  PubMed  Google Scholar 

Rakha EA, Patel A, Powe DG, Benhasouna A, Green AR, Lambros MB, et al. Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol. 2010;34:1472–9.

Article  PubMed  Google Scholar 

Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, et al. Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol. 2008;32:773–83.

Article  PubMed  Google Scholar 

Bajrami I, Marlow R, van de Ven M, Brough R, Pemberton HN, Frankum J, et al. E-Cadherin/ROS1 inhibitor synthetic lethality in breast cancer. Cancer Discov. 2018;8:498–515.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, et al. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer. Breast Cancer. 2017;24:667–72.

Article  PubMed  Google Scholar 

Mathew A, Rajagopal PS, Villgran V, Sandhu GS, Jankowitz RC, Jacob M, et al. Distinct pattern of metastases in patients with invasive lobular carcinoma of the breast. Geburtshilfe Frauenheilkd. 2017;77:660–6.

Article  PubMed  PubMed Central  Google Scholar 

Petrelli F, Barni S. Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer. Breast Cancer Res Treat. 2013;142:227–35.

Article  CAS  PubMed  Google Scholar 

Nardone A, Qiu X, Spisak S, Nagy Z, Feiglin A, Feit A, et al. A distinct chromatin state drives therapeutic resistance in invasive lobular breast cancer. Cancer Res. 2022;82:3673–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diest PJv, Shin SJ, Sasano H, Kristiansen G, Desmedt C, Reis-Filho JS. WHO Classification of Tumours Editorial Board. Breast tumours. 5th ed. ed. Lyon (France): International Agency for Research on Cancer; 2019.

De Schepper M, Vincent-Salomon A, Christgen M, Van Baelen K, Richard F, Tsuda H, et al. Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer. Mod Pathol. 2022;35:1812–20.

Article  PubMed  PubMed Central  Google Scholar 

Christgen M, Kandt LD, Antonopoulos W, Bartels S, Van Bockstal MR, Bredt M, et al. Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma. J Pathol Clin Res. 2022;8:191–205.

Article  CAS  PubMed  Google Scholar 

Cserni G, Kalman E, Udvarhelyi N, Papp E, Grote I, Bartels S, et al. Evaluation of the routine use of E-cadherin immunohistochemistry in the typing of breast carcinomas: results of a randomized diagnostic study. Histopathology. 2023;83:810–21.

Article  PubMed  Google Scholar 

De Schepper M, Koorman T, Richard F, Christgen M, Vincent-Salomon A, Schnitt SJ, et al. Integration of pathological criteria and immunohistochemical evaluation for invasive lobular carcinoma diagnosis: recommendations from the european lobular breast cancer consortium. Mod Pathol. 2024;37: 100497.

Article  PubMed  Google Scholar 

Christgen M, Cserni G, Floris G, Marchio C, Djerroudi L, Kreipe H, et al. Lobular breast cancer: histomorphology and different concepts of a special spectrum of tumors. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13153695.

Article  PubMed  Google Scholar 

Schnitt SJ, Brogi E, Chen YY, King TA, Lakhani SR. American registry of pathology expert opinions: the spectrum of lobular carcinoma in situ: diagnostic features and clinical implications. Ann Diagn Pathol. 2020;45: 151481.

Article  PubMed  PubMed Central  Google Scholar 

Grabenstetter A, Mohanty AS, Rana S, Zehir A, Brannon AR, D’Alfonso TM, et al. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations. Hum Pathol. 2020;102:44–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christgen M, Bartels S, van Luttikhuizen JL, Bublitz J, Rieger LU, Christgen H, et al. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Mod Pathol. 2020;33:2483–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agostinetto E, Nader-Marta G, Paesmans M, Ameye L, Veys I, Buisseret L, et al. ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast. Future Oncol. 2022;18:2383–92.

Article  CAS  PubMed  Google Scholar 

Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol. 2008;26:3006–14.

Article  PubMed  Google Scholar 

Yoon TI, Jeong J, Lee S, Ryu JM, Lee YJ, Lee JY, et al. Survival outcomes in premenopausal patients with invasive lobular carcinoma. JAMA Netw Open. 2023;6: e2342270.

Article  PubMed  PubMed Central  Google Scholar 

Kwon D, Ko BK, Jung SP, Kim HK, Kim EK, Jung YS, et al. Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population. PLoS ONE. 2022;17: e0262709.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao H. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast. Breast Cancer. 2021;28:187–95.

Article  PubMed  Google Scholar 

Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163:506–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCart Reed AE, Kutasovic JR, Nones K, Saunus JM, Da Silva L, Newell F, et al. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology. J Pathol. 2018;244:460–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, et al. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol. 2013;37:e1-11.

Article